DrugDiscovery AI

Accelerate molecular screening and lead identification

Research & SciencePaid

DrugDiscovery AI applies deep learning to virtual screening of compound libraries against protein targets, predicting binding affinity and ADMET properties. Pharma researchers cut early-stage screening time from weeks to hours.

Key Features

• ✓Virtual screening
• ✓Binding affinity prediction
• ✓ADMET modeling
• ✓Lead optimization
• ✓Compound library support